PerkinElmer Completes SimoTech Acquisition

PerkinElmer has completed its acquisition of SimoTech, adding end-to-end GMP automation and digital manufacturing capabilities to its life sciences services platform.

The transaction follows PerkinElmer’s August agreement to acquire the company and deepens its support for biopharmaceutical customers seeking to accelerate development and manufacturing of life-saving treatments.

Founded in 2011 and headquartered in Cork, Ireland, SimoTech is a manufacturing automation and technology services provider in the biopharmaceutical market, supporting half of the world’s top 20 pharmaceutical and biotechnology companies. It works with life sciences organizations to develop, implement and manage automation and digital manufacturing solutions that accelerate project execution, improve operational performance, increase manufacturing flexibility and maintain regulatory compliance.

For PerkinElmer, the acquisition broadens its life sciences offering by combining SimoTech’s automation and GMP IT expertise with OneSource integrated laboratory and digital solutions and Project Farma’s manufacturing and engineering services platform.

“By combining SimoTech’s expertise in manufacturing automation and digital systems with the capabilities of OneSource and Project Farma, this acquisition creates a significant opportunity to build a differentiated, scaled platform for pharmaceutical services,” said Michael Stubblefield, CEO, PerkinElmer. “We are excited to welcome SimoTech’s exceptional team to the PerkinElmer family.”

“The combination of OneSource, Project Farma and SimoTech creates a unique opportunity to strengthen our partnerships with leading innovators and reduce the time to market for life-changing therapies. SimoTech’s expertise in automation and IT systems is a natural complement to our capabilities, enabling us to support customers across the full drug development and manufacturing lifecycle. Together, we bring highly complementary capabilities that position us to deliver greater value to our customers, unlock new opportunities for growth, and realize the full potential of a differentiated, scaled pharmaceutical services platform,” said Anshul Mangal, President of PerkinElmer’s Pharma Specialty Services business.

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.